KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $5.9 billion.

  • Xylem's Total Liabilities rose 741.83% to $5.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 billion, marking a year-over-year increase of 741.83%. This contributed to the annual value of $5.6 billion for FY2024, which is 547.51% down from last year.
  • Xylem's Total Liabilities amounted to $5.9 billion in Q3 2025, which was up 741.83% from $5.9 billion recorded in Q2 2025.
  • In the past 5 years, Xylem's Total Liabilities registered a high of $6.2 billion during Q2 2023, and its lowest value of $4.4 billion during Q1 2023.
  • Moreover, its 5-year median value for Total Liabilities was $5.5 billion (2025), whereas its average is $5.4 billion.
  • Over the last 5 years, Xylem's Total Liabilities had its largest YoY gain of 3342.32% in 2023, and its largest YoY loss of 1320.57% in 2023.
  • Xylem's Total Liabilities (Quarter) stood at $5.1 billion in 2021, then fell by 11.9% to $4.4 billion in 2022, then surged by 33.42% to $5.9 billion in 2023, then decreased by 5.48% to $5.6 billion in 2024, then grew by 4.26% to $5.9 billion in 2025.
  • Its Total Liabilities stands at $5.9 billion for Q3 2025, versus $5.9 billion for Q2 2025 and $5.5 billion for Q1 2025.